Nanosensors for Detecting and Imaging of Cancer Metastasis

In some aspects, the disclosure relates to compositions and method for detection, classification, and treatment of cancer. In some embodiments, the disclosure relates to protease imaging sensors comprising a scaffold linked to an enzyme-specific substrate that includes a first detectable marker capable of being released from the prostate protease sensor when exposed to an enzyme present in cancer and a tumor imaging agent comprising a second detectable marker that is linked to the scaffold. In some embodiments, the disclosure relates to methods of monitor progression of a tumor in a subject based upon detection of detectable markers in a sample obtained from a subject who has been administered a protease imaging sensor, upon detection of a tumor imaging agent, or any combination thereof.

Researchers

Liangliang Hao / Sangeeta Bhatia

Departments: David H Koch Institute for Integrative Cancer Res, Health Sciences and Technology Program
Technology Areas: Biotechnology: Sensors & Monitoring / Chemicals & Materials: Nanotechnology & Nanomaterials / Diagnostics: Imaging Agents
Impact Areas: Healthy Living

  • sensors for detecting and imaging of cancer metastasis
    United States of America | Granted | 11,835,522
  • sensors for detecting and imaging of cancer metastasis
    European Patent Convention | Published application
  • sensors for detecting and imaging of cancer metastasis
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies